Progress and Perspective of CRISPR‐Cas9 Technology in Translational Medicine

Ruixuan Zheng, Lexiang Zhang, Rokshana Parvin, Lihuang Su, Junjie Chi, Keqing Shi, Fangfu Ye, Xiaoying Huang

Open source

DOI
10.1002/advs.202300195
Published
2023-06-25
Container
Advanced Science
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/advs.202300195,
  title = {Progress and Perspective of CRISPR‐Cas9 Technology in Translational Medicine},
  author = {Ruixuan Zheng and Lexiang Zhang and Rokshana Parvin and Lihuang Su and Junjie Chi and Keqing Shi and Fangfu Ye and Xiaoying Huang},
  year = {2023},
  journal = {Advanced Science},
  doi = {10.1002/advs.202300195},
  url = {https://doi.org/10.1002/advs.202300195}
}

RIS

TY  - JOUR
TI  - Progress and Perspective of CRISPR‐Cas9 Technology in Translational Medicine
AU  - Ruixuan Zheng
AU  - Lexiang Zhang
AU  - Rokshana Parvin
AU  - Lihuang Su
AU  - Junjie Chi
AU  - Keqing Shi
AU  - Fangfu Ye
AU  - Xiaoying Huang
PY  - 2023
JO  - Advanced Science
DO  - 10.1002/advs.202300195
UR  - https://doi.org/10.1002/advs.202300195
ER  - 

APA

Zheng, R., Zhang, L., Parvin, R., Su, L., Chi, J., Shi, K., Ye, F., & Huang, X. (2023). Progress and Perspective of CRISPR‐Cas9 Technology in Translational Medicine. Advanced Science. https://doi.org/10.1002/advs.202300195

Source records